Sep 30, 2026 · Science & Research Daily Digest
Science, space, biomedicine, and climate research highlights compiled for Sep 30, 2026, with summaries, links, and brief commentary.
I. Spaceflight and Planetary Science
1. Roman's fine guidance passes, and the coronagraph records its first focused starlight (Spaceflight)
Summary:
On Sep 30, NASA reported that the Nancy Grace Roman Space Telescope's fine-guidance system met its tests from Sep 15 to 21. Guide-star positions are reported about four times a second. The observatory holds better than 1/100,000 of a degree for half an hour during Wide Field Instrument observations, and for about eight hours during coronagraph observations. The team compared that stability to aiming a laser at a U.S. dime from about 240 kilometers, and aims to push the analogy to about 370 kilometers. On Sep 22 the Coronagraph Instrument took cosmic light for the first time and produced a focused image. On Sep 27, with detectors cooled, it saw the expected field of stars in the Large Magellanic Cloud. Spectral guiding is not yet validated. The Jet Propulsion Laboratory instrument is meant to block starlight and reveal planets and dusty disks around nearby stars.
Links:
- NASA — NASA Checks Roman Guidance System, Takes First Coronagraph Observation
- NASA JPL — NASA’s Roman Team Snaps Test Coronagraph Image
Commentary:
This is a commissioning tire check, not an exoplanet science exposure; once pointing holds, starlight suppression is the next gate.
2. Europe-China Smile is cleared for science, with auroras recorded for 45 hours (Space weather)
Summary:
On Sep 30 the European Space Agency said the joint ESA-Chinese Academy of Sciences Smile mission is approved to begin science operations. The spacecraft launched on May 19 and reached its science orbit on June 20; commissioning since then covered mechanism deployment, instrument switch-on, and spacecraft-to-ground communications. The four instruments are a soft X-ray imager, an ultraviolet aurora imager, a magnetometer, and a light ion analyser. The ultraviolet imager is the first camera since 2008 to record the full northern-lights ring in ultraviolet, and it now records auroras for 45 hours at a time. Footage from July 24 shows an auroral substorm driven by a solar-wind disturbance. The soft X-ray imager has test images of a Large Magellanic Cloud supernova remnant and Cassiopeia A, but stray light is still too high when it points at Earth. A first useful view of the magnetopause or the northern cusp is expected around mid-October.
Links:
Commentary:
Clearance for science does not mean all four instruments are at their best; the magnetopause X-ray image still waits on lower stray light.
3. Perseverance: Jezero's Margin Unit met water at least three times, not as one lakeshore deposit (Mars)
Summary:
ScienceDaily on Sep 30 relayed a NASA Jet Propulsion Laboratory account of a Communications Earth & Environment paper led by Candice Bedford of Purdue University (DOI: 10.1038/s43247-026-03997-9). When Perseverance reached Jezero Crater's inner rim in September 2023, orbital data had suggested lake sediments and carbonate. The rocks are olivine-rich igneous material instead. Across about 265 meters of elevation and more than 185 bedrock targets, SuperCam's laser can make a plasma from as far as 6.5 meters. The team reconstructs at least three water episodes: carbon-dioxide-rich groundwater left carbonate in lower-elevation fractures; a later interval, possibly tied to the lake, left more silica; still later hot fluids formed veins about 25 centimeters thick with calcium sulfate and fluorite on the eastern margin. The dates of each episode are not yet fixed.
Links:
- ScienceDaily — NASA's Perseverance Mars rover finds groundwater, lakes, and hot fluids in one place
- Communications Earth & Environment — Lake- and groundwater-associated alteration of the olivine-rich Margin unit (DOI: 10.1038/s43247-026-03997-9)
Commentary:
The Margin Unit reads as a crossroads of groundwater, lake water, and hydrothermal fluid, so habitability clues are split across three records.
II. Biomedicine
4. FDA accepts fenebrutinib for priority review in relapsing and primary progressive MS (Neurology)
Summary:
On Sep 30 Roche said the U.S. Food and Drug Administration accepted, under priority review, a new drug application for fenebrutinib, an investigational non-covalent BTK inhibitor, for relapsing multiple sclerosis and primary progressive multiple sclerosis. In the 96-week Phase III FENhance 1 and 2 trials, annualized relapse rate fell 51.1% and 58.5% versus teriflunomide. Roche equates that with about one relapse every 17 years. In FENtrepid, fenebrutinib met non-inferiority versus ocrelizumab on disability progression, with a 12% numerical reduction (hazard ratio 0.88, 95% confidence interval 0.75 to 1.03) and curves separating from about week 24. Serious adverse events were described as manageable across a safety database of more than 2,700 participants. If approved, Roche says it would be the first high-efficacy oral drug for both forms. More than 3 million people worldwide have MS, and nearly 1 million of them are in the United States.
Links:
Commentary:
Priority review puts an oral, brain-penetrant BTK inhibitor on the regulatory table; the 12% edge over ocrelizumab is still a numerical trend whose interval crosses 1.
5. Lilly: eloralintide plus tirzepatide beat either drug alone on 48-week weight loss (Metabolism)
Summary:
CNBC reported on Sep 30 that Eli Lilly presented Phase 2 results at the European Association for the Study of Diabetes in Milan. The amylin agonist eloralintide plus a low dose of tirzepatide met its main goals in adults with obesity and type 2 diabetes. Lilly plans Phase 3 by the end of 2026 and a co-formulation so both drugs can be given in one injection. At 48 weeks, 9 mg eloralintide plus 15 mg tirzepatide produced average weight loss of up to 23.3%, about 54 pounds. Tirzepatide 15 mg alone produced 14.8%, or 34.4 pounds, and eloralintide alone up to 12.3%, or 28.6 pounds. Average A1C fell by up to 2.9% on the combination, 2.4% on tirzepatide, and 1.4% on eloralintide. Discontinuation for side effects was 10.8% to 27% on the combination, depending on dose, versus 2.9% on tirzepatide alone. The most common events were mild or moderate and gastrointestinal.
Links:
Commentary:
Stacking three satiety hormones raised weight loss, and Phase 2 dropout rose with it; Phase 3 tolerability depends on the dosing changes Lilly says it will make.
6. Human tau filaments copy their fold in wild-type mouse brain (Neurodegeneration)
Summary:
Nature on Sep 30 published an open-access paper by Michel Goedert, Sjors H. W. Scheres, Masato Hasegawa, and colleagues (DOI: 10.1038/s41586-026-11061-x). Tau filaments extracted from the brains of people with Alzheimer's disease or corticobasal degeneration were injected into the striatum of wild-type mice aged 6 to 18 weeks. Nine months later, the insoluble aggregates were made of endogenous mouse tau and were negative for a human-tau antibody. Cryo-electron microscopy showed the new filaments had the same structures as the seeds. Alzheimer's seeds produced mainly neuronal inclusions. Corticobasal degeneration seeds entered both neurons and glia, including coiled bodies and plaque-like astrocytic inclusions typical of that disease. The result is direct evidence that a tau conformational strain keeps its structural identity after transmission.
Links:
Commentary:
The fold itself templates mouse tau, so disease differences look like strain differences rather than a requirement that the host express human tau.
7. Prior type 2 immunity trains lung macrophages to tolerate lethal flu without cutting viral load (Immunology)
Summary:
Nature on Sep 30 published a paper led by Kamal M. Khanna (DOI: 10.1038/s41586-026-11060-y). Mice were infected with about 600 Nippostrongylus brasiliensis larvae and, 4 to 6 weeks later, challenged with a lethal dose of H1N1 PR8 influenza. Every mouse with that type 2 immune history survived. Every unconditioned control reached the endpoint by days 5 to 6. Infectious virus at days 1, 3, and 6 did not differ. Protection tracked with less immunopathology, more efferocytosis, and faster repair, and it required nerve- and airway-associated macrophages. Depleting those cells or replacing them with untrained ones removed protection; transferring trained ones conferred tolerance. The chromatin program implicated is IL-4, STAT6, PPARγ, and ARG1. Human lung single-cell atlases from idiopathic pulmonary fibrosis and COPD show context-dependent repair programs of a similar kind.
Links:
Commentary:
Survival here is less tissue damage, not better viral clearance, and a parasite-then-flu mouse sequence is not yet a clinical flu strategy.
8. An immune multiome of 1,108 Finns turns more than half of immune-disease associations into testable mechanisms (Genomics)
Summary:
Nature on Sep 30 published a FinnGen paper (DOI: 10.1038/s41586-026-11078-2). Paired single-nucleus chromatin-accessibility and RNA sequencing of 10 million peripheral blood mononuclear cells from 1,108 Finnish donors yielded 51,083 cis-expression QTLs for 20,829 genes, 338,100 cis-chromatin accessibility QTLs for 210,584 peaks, 119,094 putative causal variants, and 593,765 peak-gene links. Variants that complete a chromatin-to-expression cascade show twice the disease colocalization of chromatin-only effects. Massively parallel reporter assays validated 10,428 fine-mapped molecular QTLs. At evolutionarily constrained genes, chromatin effects are ordinary in size, but transmission to expression is buffered by weaker and more numerous enhancer-gene links. The atlas supplies testable hypotheses for more than half of immune-disease associations.
Links:
Commentary:
Buffering sits at the chromatin-to-expression step, which is why constrained genes can be rich in disease variants and poor in expression QTLs.
III. Climate Attribution
9. Carbon Impacts Tracer converts one fossil-fuel project's emissions into warming and eight harms (Climate)
Summary:
Researchers at the Australian National University and UNSW Sydney described the open-source Carbon Impacts Tracer on Sep 30. It uses the IPCC relation of about 0.45°C of warming per trillion tonnes of carbon dioxide, then maps that warming onto eight damage types whose evidence cleared a high bar, including crop loss and heatwave deaths in Europe. Preset cases cover five proposed Australian projects, one in the United Kingdom, and future emissions from 16 major fossil-fuel companies from 2024 to 2050. Woodside's proposed Browse to North West Shelf gas project is given as 1,597 megatonnes of CO2 over its life, 0.00072°C of warming, and almost 200,000 more people enduring an extra week of dangerous heat each year. ExxonMobil's future emissions of 5,245 megatonnes correspond to an extra 0.0024°C and an extra 127 square kilometers of glacier loss. Users can enter other emissions and generate a report with the underlying studies. Heatwave deaths outside Europe, including in Australia, are not yet included.
Links:
- UNSW — We can finally measure the damage each new coal, gas or oil project will do
- ANU ICEDS — We can finally measure the damage each new coal, gas or oil project will do to people and nature
Commentary:
The tool replaces a drop-in-the-ocean claim with citable harm ranges, and it only covers the eight endpoints whose evidence met the authors' bar.
IV. Basic Research and Biological Design
10. DeepMind's SynthIDBio watermarks AI-designed proteins without losing binding (Biosecurity)
Summary:
Nature on Sep 30 published an open-access paper from Google DeepMind, including David Stutz, Demis Hassabis, and Pushmeet Kohli (DOI: 10.1038/s41586-026-10965-y). SynthIDBio-sequence biases ProteinMPNN's amino-acid sampling with a secret key and writes a watermark only where the choice still fits a functional protein. In vitro, the team obtained low-nanomolar binders to the SARS-CoV-2 receptor-binding domain and subnanomolar binders to VEGF-A and PD-L1. Watermarking did not change the affinity distribution or hit rate, and detection was near perfect. SynthIDBio-structure fine-tunes AlphaFold 3 so that predicted structures carry an imperceptible watermark with a negligible effect on global accuracy. The authors call the work a proof of concept and say biosecurity or database use will need further methods plus industry coordination and standards.
Links:
- Nature — Function-preserving watermarking of AI-generated proteins
- Ars Technica — Google figures out how to watermark AI-designed proteins
Commentary:
The watermark can survive function, and key handling, very short sequences, and other design software still decide whether it can screen DNA orders.
11. JWST makes the first secure detection of the methyl radical around a dying carbon-rich star (Astrochemistry)
Summary:
On Sep 30 the Instituto de Astrofísica de Canarias announced an Astrophysical Journal Letters paper by Jialu Li, Domingo Aníbal García-Hernández, Arturo Manchado, and colleagues (DOI: 10.3847/2041-8213/aea794). JWST's Mid-Infrared Instrument securely detected the methyl radical CH3 in SMP LMC 011, a carbon-rich planetary nebula in the Large Magellanic Cloud. The molecule is nearly radio-silent because of its symmetry, and the diagnostic vibration sits in mid-infrared light that Earth's atmosphere blocks. The measured abundance is too high for ordinary gas-phase routes such as ultraviolet breakup of methane. The team argues that hydrogenated amorphous carbon dust is eroded by ultraviolet light or shocks and returns CH3 to the gas. Ethane was not detected, so methyl is not mainly pairing with itself; it is more likely adding to benzene on the way to toluene and ethylbenzene.
Links:
- IAC — JWST detects the elusive methyl radical for the first time around a dying star
- The Astrophysical Journal Letters — Detection of the methyl radical CH3 in SMP LMC 011 (DOI: 10.3847/2041-8213/aea794)
Commentary:
Dust is not only a sink for aromatic molecules; it can be broken down and fed back into the gas, and carbon-star chemical models need that loop.
12. Technion uses two-color laser pulses to steer attosecond currents in a scanning tunneling microscope (Ultrafast physics)
Summary:
Nature Photonics on Sep 30 published a paper from Michael Krüger's group at the Technion, with collaborators at Université Paris-Saclay and the Fritz Haber Institute (DOI: 10.1038/s41566-026-02021-y). Two-color laser pulses drive tunneling current in a scanning tunneling microscope junction, and the sub-cycle waveform alone reverses the current direction. Mapping the data onto one-electron and many-body theory gives a three-step transport process in the non-adiabatic tunneling regime, with a theory-derived current burst of 860 attoseconds. Under ambient conditions and free of thermal artifacts, the experiment reaches sub-angstrom topographic sensitivity and 2-nanometer lateral resolution. Funding came from the European Research Council and the Israel Science Foundation.
Links:
Commentary:
A steerable attosecond current burst adds the missing time knob to scanning tunneling microscopy; 860 attoseconds is a theoretical projection, not a direct stopwatch reading.
Today's Summary
- Space and planets: Roman's fine guidance held better than 1/100,000 of a degree, and the coronagraph took its first focused image. Europe-China Smile was cleared for science, with soft X-ray views of Earth still limited by stray light. Perseverance separated at least three water episodes in Jezero's Margin Unit.
- Medicine: Fenebrutinib entered FDA priority review after cutting relapses by about half versus teriflunomide. Lilly's amylin-plus-tirzepatide regimen reached 23.3% weight loss at 48 weeks, with higher dropout. Tau folds copied themselves in wild-type mice, and a type 2 immune history protected mice from lethal flu by limiting damage rather than viral load.
- Climate: Carbon Impacts Tracer turns 0.45°C per trillion tonnes of CO2 into eight harm types. The Browse gas project maps to about 200,000 more people facing an extra week of dangerous heat each year.
- Basic research: SynthIDBio watermarked designed proteins without losing binding. JWST detected the methyl radical in the Large Magellanic Cloud. A scanning-tunneling current burst is estimated at 860 attoseconds.
Daily Framing:
Today was a commissioning-and-mechanism day: Roman's coronagraph took its first focused image and Smile was cleared for science, while tau folds kept their structure in mouse brains, a protein watermark stayed functional, and an oral BTK inhibitor moved into priority review.
This digest is compiled from real-time search results and is for reference only.